Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

EHTH earnings analysis

Filed May 6, 2026 · Our reading of the company's report

The latest report

eHealth, Inc. reported Q1 2026 total revenue of $88 million, outperforming estimates by 10%, while diluted EPS was reported at -$0.38, exceeding estimates by $0.11. Despite these surprises, the company is facing…

Read full summary

eHealth, Inc. reported Q1 2026 total revenue of $88 million, outperforming estimates by 10%, while diluted EPS was reported at -$0.38, exceeding estimates by $0.11. Despite these surprises, the company is facing significant challenges with a 22% decline in total revenue compared to the same quarter last year and a 64% drop in approved Medicare Part D members. Management has indicated a focus on reducing variable marketing spend and enhancing member lifetime value through new technologies.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

100% Gross margin Operating margin May 2025 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $0 Operating expenses $103 Left as operating profit $-3

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish May 2025 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$-0.38
Segment
Medicare
Segment
Employer and Individual

What stood out

  • Revenue Exceeds Estimates

    Q1 2026 revenue was $88.02 million, exceeding estimates of $80 million by approximately 10%.

  • EPS Surprises on the Upside

    Diluted EPS came in at -$0.38, outperforming expectations of -$0.70 by $0.11.

  • Significant Cost Savings Initiated

    The company implemented a cost reduction initiative, achieving $6.4 million in restructuring charges.

  • Increased Medicare Part D Commissions

    Commissions for Medicare Part D increased by 78%, reflecting improvements in sales despite overall declines in enrollment.

  • Strong Cash Position Maintained

    As of March 31, 2026, cash and cash equivalents totaled $75.1 million, up from $73.7 million at the end of 2025.

  • Operating Cash Flow Improvement

    Net cash provided by operating activities was $35.8 million for Q1 2026, driven by improved changes in net operating assets.

What to watch

  • Steep Decline in Revenue

    Total revenue decreased by $25.1 million, or 22%, from $113.1 million in Q1 2025 to $88.0 million in Q1 2026.

  • Dropping Approved Members

    Total approved members decreased by 21% year-over-year, driven by a 24% decline in Medicare approvals.

  • Increased Impairment Charges

    The company recognized $6.4 million in restructuring and impairment charges, potentially impacting future profitability.

Management's outlook

Full-year 2026 revenue guidance remains unchanged at $405 million to $445 million.

Earlier filings 4

10-K · February 26, 2026

eHealth, Inc. reported a notable increase in Q4 2025 revenue to $326.24 million, exceeding expectations of $317.41 million, although EPS fell short at $2.06 versus the estimated $2.34. The company is adjusting its…

10-Q · November 6, 2025

eHealth, Inc. reported Q3 2025 earnings showing a decline in revenue to $53.87 million, missing the prior year's $58.41 million. However, the company reduced its EPS loss to $1.46, better than the expected loss of…

10-Q · August 7, 2025

eHealth, Inc. reported a significant decline in total revenue in Q2 2025 compared to both the prior year and prior quarter, alongside a notable increase in net loss. The Medicare segment showed slight growth in…

10-Q · May 7, 2025

eHealth, Inc. reported a strong Q1 2025, with revenue rising to $113.1 million, up 22% year-over-year, significantly surpassing consensus estimates. The company achieved an EPS loss of $0.20, an improvement compared to…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.